🔎 Trials Near Me

Akèy › Limfòm Burkitt › Rhode Island › Providence

Etid klinik pou Limfòm Burkitt nan Providence, RI

7 etid pou Limfòm Burkitt ap chèche patisipan nan sit nan ak bò kote Providence (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Ap rekriteFaz 3
  • Rhode Island Hospital, Providence
Laj 18 a 39 · Tout sèks · Mizajou Oct 2, 2026 · NCT03150693

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Ap rekriteFaz 1
  • Lifespan Cancer Institute at Rhode Island Hospital, Providence
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT03666000

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Ap rekriteFaz 2
  • Rhode Island Hospital, Providence
Laj 1 a 30 · Tout sèks · Mizajou Sep 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Ap rekriteFaz 3
  • Rhode Island Hospital, Providence
365 Days – 25 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03959085

Study of SGR-1505 in Mature B-Cell Neoplasms

Ap rekriteFaz 1
  • Rhode Island Hospital, Providence
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT05544019

Etid Limfòm Burkitt nan lòt vil

Lòt etid nan Providence

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.